Signet Financial Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $247K | Buy |
8,800
+20
| +0.2% | +$532 | 0.03% | 278 |
|
|
2025
Q4 | $219K | Buy |
8,780
+95
| +1% | +$2.4K | 0.02% | 281 |
|
|
2025
Q3 | $221K | Sell |
8,685
-355
| -4% | -$8.76K | 0.03% | 281 |
|
|
2025
Q2 | $219K | Buy |
9,040
+767
| +9% | +$17.9K | 0.03% | 275 |
|
|
2025
Q1 | $210K | Sell |
8,273
-2,710
| -25% | -$70.9K | 0.03% | 274 |
|
|
2024
Q4 | $291K | Buy |
10,983
+182
| +2% | +$4.94K | 0.04% | 231 |
|
|
2024
Q3 | $313K | Sell |
10,801
-111
| -1% | -$3.24K | 0.04% | 225 |
|
|
2024
Q2 | $305K | Sell |
10,912
-790
| -7% | -$21.8K | 0.04% | 219 |
|
|
2024
Q1 | $325K | Sell |
11,702
-29,889
| -72% | -$829K | 0.04% | 223 |
|
|
2023
Q4 | $1.2M | Buy |
41,591
+1,730
| +4% | +$52.3K | 0.18% | 140 |
|
|
2023
Q3 | $1.32M | Buy |
39,861
+1,773
| +5% | +$62.7K | 0.22% | 130 |
|
|
2023
Q2 | $1.4M | Sell |
38,088
-259
| -0.7% | -$10.1K | 0.22% | 132 |
|
|
2023
Q1 | $1.56M | Buy |
38,347
+1,503
| +4% | +$64.9K | 0.26% | 121 |
|
|
2022
Q4 | $1.89M | Buy |
36,844
+2,506
| +7% | +$120K | 0.34% | 90 |
|
|
2022
Q3 | $1.5M | Buy |
34,338
+220
| +0.6% | +$10.7K | 0.29% | 92 |
|
|
2022
Q2 | $1.79M | Sell |
34,118
-2,061
| -6% | -$105K | 0.34% | 82 |
|
|
2022
Q1 | $1.87M | Sell |
36,179
-274
| -0.8% | -$14.2K | 0.31% | 88 |
|
|
2021
Q4 | $2.15M | Sell |
36,453
-3,018
| -8% | -$150K | 0.33% | 79 |
|
|
2021
Q3 | $1.7M | Buy |
+39,471
| New | +$1.75M | 0.29% | 93 |
|
|
2021
Q2 | – | Sell |
-36,712
| Closed | -$1.33M | – | 205 |
|
|
2021
Q1 | $1.33M | Buy |
36,712
+3,164
| +9% | +$112K | 0.25% | 104 |
|
|
2020
Q4 | $1.24M | Buy |
33,548
+379
| +1% | +$13.9K | 0.25% | 98 |
|
|
2020
Q3 | $1.18M | Buy |
33,169
+2,578
| +8% | +$90.4K | 0.26% | 102 |
|
|
2020
Q2 | $1.11M | Sell |
30,591
-12,444
| -29% | -$423K | 0.25% | 97 |
|
|
2020
Q1 | $1.52M | Buy |
43,035
+5,705
| +15% | +$194K | 0.36% | 83 |
|
|
2019
Q4 | $1.39M | Buy |
37,330
+923
| +3% | +$32.9K | 0.26% | 103 |
|
|
2019
Q3 | $1.28M | Sell |
36,407
-36,211
| -50% | -$1.32M | 0.25% | 105 |
|
|
2019
Q2 | $2.97M | Sell |
72,618
-784
| -1% | -$31.1K | 0.59% | 66 |
|
|
2019
Q1 | $2.86M | Sell |
73,402
-2,155
| -3% | -$86.3K | 0.56% | 71 |
|
|
2018
Q4 | $3.13M | Buy |
75,557
+308
| +0.4% | +$12.8K | 0.68% | 54 |
|
|
2018
Q3 | $3.15M | Buy |
75,249
+1,104
| +1% | +$42.5K | 0.55% | 68 |
|
|
2018
Q2 | $2.55M | Sell |
74,145
-597
| -0.8% | -$20.4K | 0.45% | 74 |
|
|
2018
Q1 | $2.52M | Sell |
74,742
-4,262
| -5% | -$147K | 0.45% | 73 |
|
|
2017
Q4 | $2.71M | Sell |
79,004
-604
| -0.8% | -$20.6K | 0.51% | 66 |
|
|
2017
Q3 | $2.7M | Sell |
79,608
-2,004
| -2% | -$64.4K | 0.53% | 65 |
|
|
2017
Q2 | $2.6M | Sell |
81,612
-1,806
| -2% | -$57K | 0.55% | 62 |
|
|
2017
Q1 | $2.71M | Buy |
83,418
+24,191
| +41% | +$763K | 0.59% | 61 |
|
|
2016
Q4 | $1.83M | Sell |
59,227
-2,720
| -4% | -$83K | 0.44% | 66 |
|
|
2016
Q3 | $1.99M | Buy |
61,947
+6,361
| +11% | +$213K | 0.47% | 62 |
|
|
2016
Q2 | $1.86M | Sell |
55,586
-2,535
| -4% | -$80.9K | 0.43% | 65 |
|
|
2016
Q1 | $1.63M | Buy |
58,121
+10,118
| +21% | +$289K | 0.34% | 67 |
|
|
2015
Q4 | $1.47M | Buy |
48,003
+6,668
| +16% | +$210K | 0.3% | 71 |
|
|
2015
Q3 | $1.23M | Buy |
41,335
+8,862
| +27% | +$284K | 0.28% | 70 |
|
|
2015
Q2 | $1.03M | Sell |
32,473
-1,149
| -3% | -$37.4K | 0.24% | 77 |
|
|
2015
Q1 | $1.11M | Buy |
33,622
+22,089
| +192% | +$702K | 0.31% | 74 |
|
|
2014
Q4 | $341K | Buy |
+11,533
| New | +$331K | 0.12% | 117 |
|
Other funds holding PFE
VCM
VPM
Signet Financial Management's PFE Position: Q1 2026 in Review
Signet Financial Management increased its Pfizer (PFE) stake by 0.23% in Q1 2026, buying an estimated $532 and bringing the position to 8,800 shares worth $247K. The position accounts for 0.03% of the portfolio, ranked #278.
Signet Financial Management first reported a position in PFE in Q4 2014 and has held it in 45 quarters since. The position peaked at $3.15M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Signet Financial Management held 8,800 shares of Pfizer worth $247K as of Q1 2026.
- Signet Financial Management bought 20 Pfizer shares in Q1 2026, an estimated $532.
- Pfizer made up 0.03% of Signet Financial Management's portfolio in Q1 2026, its #278 holding.
- Signet Financial Management first reported a position in Pfizer in Q4 2014 and has held it in 45 quarters since.
- Signet Financial Management's Pfizer position peaked at $3.15M in Q3 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.